Pineapple Financial has stepped into the digital treasury with Injective (INJ).

Recently, Injective (INJ) has caught the attention of cryptocurrency investors, as the Canadian financial giant Pineapple Financial (PAPL) made a significant purchase. The company established the foundations of its digital asset treasury by acquiring approximately $8.9 million worth of 678,353 Injective tokens from the open market. This investment is reported to be part of a $100 million private investment plan.

This strategic move by Pineapple Financial is seen as a step towards its goal of building a digital treasury. The company's CEO stated that this acquisition is not solely aimed at achieving short-term gains but also signifies the beginning of a long-term Injective (INJ) accumulation plan. In this context, Pineapple Financial aims to increase its Injective holdings through open market purchases in the upcoming period.

In addition to its activities in traditional finance, Pineapple Financial plans to grow in the digital asset management sector. This digital treasury initiative, starting with Injective, demonstrates that institutional investors still have an ongoing interest in decentralized finance (DeFi)-based projects. Currently, according to CoinGecko data, the price of Injective (INJ) is trading around $12.54.

Looking ahead, it is likely that investors will show more interest in the Injective (INJ) asset, and the position of such digital assets in the markets may strengthen. The shift of institutional investors towards DeFi projects could change the dynamics in the cryptocurrency market. In light of these developments, key points for investors to monitor include fluctuations in Injective prices and Pineapple Financial's future acquisition strategies.